NCT01675258 Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic Cancers Status UNKNOWN Phase N/A
NCT01674959 Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients Status UNKNOWN Phase PHASE2
NCT01672333 Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma Status COMPLETED Phase PHASE2
NCT01671449 S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT01665274 Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancer Status TERMINATED Phase PHASE2
NCT01662869 A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer Status COMPLETED Phase PHASE3
NCT01655641 Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT01650766 Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers Status UNKNOWN Phase N/A
NCT01641939 A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT01637350 Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes Status UNKNOWN Phase N/A
NCT01633203 Observational Study of Perioperative Chemotherapy in Gastric Cancer Status COMPLETED Phase N/A
NCT01627119 The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer Status UNKNOWN Phase N/A
NCT01625702 Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer Status COMPLETED Phase NA
NCT01621919 Concentration of S-1 Metabolites in Tear and Plasma of Patients Receiving TS-1 Status UNKNOWN Phase N/A
NCT01614522 A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 Status COMPLETED Phase PHASE2
NCT01611506 Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01590719 A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer Status COMPLETED Phase PHASE2
NCT01584336 Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03) Status UNKNOWN Phase PHASE2